Press Releases

RSS
  • Oct 27, 2016
    ENGLEWOOD, Colo., Oct. 27, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it has priced an underwritten public offering of 5,735,000 shares of its common stock and warrants to purchase up to an aggregate of 5,735,000 shares of its common stock at a comb...
    Sep 14, 2016
    ENGLEWOOD, Colo., Sept. 14, 2016 /PRNewswire/ -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at two upcoming investor conferences in September 2016. ...
    Sep 13, 2016
    Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...
    Sep 6, 2016
    Company invites individual and institutional investors to attend interactive real-time virtual VirtualInvestorConferences.com...
    Sep 6, 2016
    ENGLEWOOD, Colo., Sept. 6, 2016 /PRNewswire/ -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Chief Operating Officer Jarrett Disbrow will present at the 2016 BioPharm America Conference, to be held September 13-15, 2016, at the Boston Marriott Copley Place in Boston, MA....
    Sep 1, 2016
    ENGLEWOOD, Colo., Sept. 1, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, provided today a review of its recent accomplishments and provided an overview of its business and growth strategy, as well as its operational and financial results for the fiscal year ended June 30,...
    Aug 25, 2016
    ENGLEWOOD, Colo., Aug. 25, 2016 /PRNewswire/ -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced today that the company will present its operational results for the fourth and final quarter of fiscal 2016 on Thursday, September 1, 2016, at 4:30 p.m. ET.  The company will review recent a...
    Aug 18, 2016
    ENGLEWOOD, Colo., Aug. 18, 2016 /PRNewswire/ -- Aytu BioScience Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it will present at the Rodman & Renshaw 18th Annual Global Investment Conference, held September 11-13, 2016, at the Lotte New York Palace Hotel in New York City.  ...
    Jul 28, 2016
    ENGLEWOOD, Colo., July 28, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU) ("Aytu"), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, announced today that it has entered into a $10.5 million common stock purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), a Chicago-based institutional investor.  Upon execution ...
    Jul 21, 2016
    ENGLEWOOD, Colo., July 21, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the publication of the first peer-reviewed journal article demonstrating the clinical utility of the Company's MiOXSYS™ System for assessing the level of oxidative stress in semen as...